Topical bevacizumab for the treatment of corneal vascularization in dogs: A case series-Reference-Cited by-同舟云学术

Topical bevacizumab for the treatment of corneal vascularization in dogs: A case series

Published:2021-09 Issue:5 Volume:24 Page:554-568
ISSN:1463-5216
Container-title:Veterinary Ophthalmology
language:en
Short-container-title:Vet Ophthalmol

Author:

Muellerleile Lisa‐Marie¹^ORCID,Bernkopf Michael²^ORCID,Wambacher Michael³^ORCID,Nell Barbara¹

Affiliation:

1. Department of Companion Animals and Horses University of Veterinary Medicine Vienna Vienna Austria

2. E‐Learning and New Media University of Veterinary Medicine Vienna Vienna Austria

3. Hospital Pharmacy University of Veterinary Medicine Vienna Vienna Austria

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vop.12931

Reference69 articles.

1. Loss and restoration of immune privilege in eyes with corneal neovascularization;Dana M;Investig Ophthalmol Vis Sci,1996

2. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas;Philipp W;Investig Ophthalmol Vis Sci,2000

3. Characteristics of, prevalence of, and risk factors for corneal pigmentation (pigmentary keratopathy) in Pugs

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bevacizumab Efficiently Inhibits VEGF-Associated Cellular Processes in Equine Umbilical Vein Endothelial Cells: An In Vitro Characterization;Veterinary Sciences;2023-10-26

2. Effects of commercial amniotic membrane extract on the re‐epithelialization time and the early expression of matrix metalloproteinase‐9 in cats with experimentally induced corneal ulcers;Veterinary Ophthalmology;2022-09-12